MAUDE Adverse Event Report: GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) BD MAX¿ CHECK-POINTS (CPO); MULTIPLE-GENUS RESPIRATORY VIRUS NUCLEIC ACID IVD KIT

Catalog Number	445262
Medical Device Problem Code	False Negative Result (1225)
Health Effect - Clinical Code	No Clinical Signs, Symptoms or Conditions (4582)
Date of Event	02/27/2025
Type of Reportable Event	Malfunction
Additional Manufacturer Narrative
D.2.Additional medical device types: poc.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
Event or Problem Description
It was reported that during use of bd max¿ cpo, a false negative vim/imp patient result was obtained.The culture was positive, and immunochromatography yielded vim.There was no report of patient impact.
Additional Manufacturer Narrative
Investigation summary: the complaint investigation for suspected false negative results when using bd max¿ cpo (ref.445262) kit lot 4194273 was performed by the review of manufacturing records, retain material inspection, review of customer¿s data and by the complaint¿s history review.The review of quality control records of bd max¿ cpo lot 4194273 revealed no anomalies that could explain the customer¿s negative results.The retain material of bd max¿ cpo from lot 4194273 was visually inspected showed no anomaly.However, kit lot 4194273 was expired at the time the complaint was investigated, and no conclusion was possible concerning performance.Customer reported one of their samples (last three digits of accession number #401) presented a positive curve in the vic channel (vim/imp-1-2 targets), but the software interpreted the result as negative.According to customer, this is an issue with the interpretation of a positive result with the bd max¿ cpo assay.They mentioned having cultured the sample, which tested positive and immunochromatography detected vim.Customer provided run files for run 291 from bd max¿ instrument ct3187 for the investigation.Manual pcr curve adjudication of the sample in position b8 revealed a weak pcr amplification curve with a late ct value and low endpoint.Despite the signal in the vic channel (vim/imp-1-2 targets), the result was negative by the bd max¿ because the signal did not reach the ct and endpoint threshold values to be considered valid by the algorithm.For sample b8 of run 291, the signal was too late, explaining the negative vim/imp-1-2 result.As stated in the instruction for use ¿limitations of the procedure¿ section, the bd max¿ system provides qualitative results.Any reported ct value or displayed curve should only be used to the purposes of laboratory quality control trending, research, and public health reporting.A negative result was the expected result in such condition.It must also be noted that limit of detection can vary between different assays and testing methods.Nevertheless, manual curve adjudication has limitations; visual examination of pcr curves for low signal is a conservative assessment of the data.There is no indication of a reagent issue based on the analysis of the complaints received for discrepant results on bd max¿ cpo kit lot 4194273.The root cause was not identified.However, a sample with a concentration beyond the ct values limits of detection of the assay is the most likely cause to explain the customer¿s discrepant results.Bd cannot confirm the complaint based on the investigation that was performed.Bd did not initiate a corrective and preventive action since no new hazard was identified.Bd apologizes for the inconvenience that this may have caused.Bd quality will continue to monitor for trends.
Event or Problem Description
It was reported that during use of bd max¿ cpo, a false negative vim/imp patient result was obtained.The culture was positive, and immunochromatography yielded vim.There was no report of patient impact.

• Brand Name: BD MAX¿ CHECK-POINTS (CPO)
• Common Device Name: MULTIPLE-GENUS RESPIRATORY VIRUS NUCLEIC ACID IVD KIT
• Manufacturer (Section D): GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS); 2555 blv. du parc techn; quebec
• Manufacturer (Section G): GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS); 2555 blv. du parc techn; quebec
• Manufacturer Contact: matt j. connor ; 7 loveton circle; sparks, MD 21152 ; 4103164000
• MDR Report Key: 23066925
• Report Number: 3007420875-2025-00154
• Device Sequence Number: 9849896
• Product Code: OOI
• UDI-Device Identifier: 00382904452629
• UDI-Public: (01)00382904452629(17)250619(10)4194273
• Combination Product (Y/N): N
• Initial Reporter Country: CI
• PMA/510(K) Number: K190613
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Serviced by Third Party (Y/N): N
• Reporter Type: Manufacturer
• Report Source: Other,Foreign,User Facility
• Initial Reporter Occupation: Other Health Care Professional
• Type of Report: Initial,Followup
• Report Date (Section B): 12/12/2025

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: No
• Is this a Product Problem Report?: Yes
• Operator of Device: Other
• Device Expiration Date: 06/19/2025
• Device Catalogue Number: 445262
• Device Lot Number: 4194273
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 08/20/2025
• Supplement Date Received by Manufacturer: 12/12/2025
• Initial Report FDA Received Date: 09/16/2025
• Supplement Report FDA Received Date: 12/16/2025
• Was Device Evaluated by Manufacturer? (Y/N): No
• Date Device Manufactured: 07/12/2024
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Patient Sex: Unknown